Cerner has announced an agreement to acquire a data, analytics and research consultancy for £282 million.
The acquisition of the health division of Kantar Health, a London based global analytics company, is expected to support Cerner’s client base engage with life sciences for funded research studies, and harness data initiatives on a large scale.
Kantar Health employs 28,000 people and works across 90 markets, supporting organisations collect data digitally and share insights in real time, offering self service solutions, and AI and machine learning tools.
Lynnette Cooke, CEO, Kantar Health, commented: “At Kantar Health we’re proud of our heritage and reputation as consultants to the world’s leading life sciences manufacturers. We are excited about this next chapter, where our real-world evidence and commercial data assets will be powered by Cerner.”
“There is a strong cultural fit between the two organisations, grounded by our shared vision to increase access and affordability for patients around the world. We expect the combination of our expertise and assets with Cerner’s technology and unique insights into patients will enable a step-change in the way healthcare is developed and delivered, resulting in improved patient outcomes.”
Donald Trigg, president, Cerner, added: “Cerner launched the Learning Health Network with our provider clients to advance a shared vision: treat global diseases more effectively through an acceleration of clinical research.”
“Kantar Health has incredible health economics and medical affairs expertise, differentiated real-world data assets and strong relationships with the world’s leading life science companies. It offers us an amazing opportunity to drive cross-industry collaboration that can change health outcomes around the world.”
The acquisition is anticipated to close in the first half of 2021.
